Pharmacogenomic testing for antidepressants could help reduce the time and cost it takes to find the most effective medication for a patient, according to a new study. Scientists developed a ...

A DNA test could help match patients with psychiatric medications, potentially reducing the long and frustrating trial-and-error process.

New Orleans-based Ochsner Health was met with some uncertainty when it launched its pharmacogenomic program in March 2022 and became one of the first health systems to standardize genomic testing.

Pharmacogenomic testing, a mature and growing aspect of personalized medicine, has demonstrated significant ability to enhance health outcomes and reduce healthcare costs. Since the 1970s, ...

LAS VEGAS -- Families who received the results of pharmacogenomic testing for their children at one center understood the results they received but didn't often share the test results with other ...

CLEVELAND — Imagine if you could know if that medication your doctor is about to prescribe would even work for you. The technology is real. It's called pharmacogenomics, and some hope it becomes part ...

Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy ...

Pharmacogenetic testing, which is used to classify how patients with major depressive disorder (MDD) metabolize medications, reduces adverse drug-gene interactions, new research shows. In a randomized ...